Implitapide
Alternative Names: AEGR 427 implitapide; AEGR-427; BAY 13-9952Latest Information Update: 14 Apr 2023
At a glance
- Originator Bayer
- Class Antihyperlipidaemics; Indoles; Pyridines
- Mechanism of Action Microsomal triglyceride transfer protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Suspended Hypercholesterolaemia
- Discontinued Hyperlipidaemia; Hyperlipoproteinaemia type II; Hypertriglyceridaemia
Most Recent Events
- 12 Apr 2023 Amryt Pharma has been acquired by Chiesi Farmaceutici
- 25 Sep 2019 Aegerion Pharmaceuticals has been acquired and merged into Amryt Pharma
- 29 Nov 2016 QLT acquired Aegerion Pharmaceuticals and later QLT changed its name to Novelion Therapeutics